Advertisement

Topics

BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

15:18 EDT 4th May 2016 | BioPortfolio

Updates and info from the contributors bringing you BioPortfolio.com.

Showing News Articles 1–5 of 1,200+

Monday 18th April 2016

Cortina Asset Management LLC Reduces Stake in Inogen Inc

Cortina Asset Management LLC decreased its position in Inogen Inc by 1.5% during the fourth quarter, Holdings Channel reports. The fund owned 423,068 shares of the medical technology company's stock after selling 6,367 shares during the period.

Do genetic 'unicorns' hold keys to cures?

Somewhere in the world are 13 incredibly lucky people, whether they know it or not. Each inherited a mutated gene that causes a fatal or terribly debilitating disease in infancy or childhood -- but these people are adults, and healthy.

Great Lakes Advisors LLC Acquires 11,853 Shares of Bristol-Myers Squibb Co

Great Lakes Advisors LLC raised its position in Bristol-Myers Squibb Co by 28.1% during the fourth quarter, Holdings Channel reports. The firm owned 54,054 shares of the biopharmaceutical company's stock after buying an additional 11,853 shares during the period.

Bristol-Myers Squibb Co (BMY) Expected to Earn Q1 2016 Earnings of $0.65 Per Share

Bristol-Myers Squibb Co - Equities researchers at Jefferies Group issued their Q1 2016 earnings estimates for Bristol-Myers Squibb in a report released on Friday, Zacks Investment Research reports. Jefferies Group analyst J. Holford expects that the brokerage will post earnings per share of $0.65 for the quarter.

Research Analysts Offer Predictions for Bayer AG's Q1 2016 Earnings

Analysts at Jefferies Group issued their Q1 2016 earnings estimates for Bayer AG in a report released on Friday, according to Zacks Investment Research . Jefferies Group analyst J. Holford anticipates that the brokerage will earn $2.45 per share for the quarter.


Quick Search
Advertisement